{"id":"https://openalex.org/W863506","doi":null,"title":"Alpha-interferon for chronic active hepatitis B in human immunodeficiency virus-infected patients.","display_name":"Alpha-interferon for chronic active hepatitis B in human immunodeficiency virus-infected patients.","alternate_titles":[],"publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W863506","mag":"863506","pmid":"https://pubmed.ncbi.nlm.nih.gov/9119186"},"language":"en","primary_location":{"id":"pmid:9119186","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9119186","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gastroenterologie clinique et biologique","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W863506"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112016041","display_name":"H. Zylberberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1288880153","display_name":"H\u00f4pital Necker-Enfants Malades","ror":"https://ror.org/05tr67282","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4210120235"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"H Zylberberg","raw_affiliation_strings":["Unit\u00e9 d'H\u00e9patologie, H\u00f4pital Necker, Paris"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit\u00e9 d'H\u00e9patologie, H\u00f4pital Necker, Paris","institution_ids":["https://openalex.org/I1288880153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025783802","display_name":"Jianhai Jiang","orcid":"https://orcid.org/0000-0001-9195-9302","observed_orcids":["https://orcid.org/0000-0001-9195-9302"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Jiang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105785204","display_name":"Gilles Pialoux","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Pialoux","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113769370","display_name":"F. Driss","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Driss","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106469905","display_name":"Fran\u00e7oise Carnot","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Carnot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045236304","display_name":"Fr\u00e9d\u00e9ric Dubois","orcid":"https://orcid.org/0000-0001-6972-9869","observed_orcids":["https://orcid.org/0000-0001-6972-9869"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Dubois","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103002558","display_name":"Christian Br\u00e9chot","orcid":"https://orcid.org/0000-0002-2353-9362","observed_orcids":["https://orcid.org/0000-0002-2353-9362"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Brechot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"P Berthelot","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Berthelot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5076282431","display_name":"Stanislas Pol","orcid":"https://orcid.org/0000-0001-9772-9591","observed_orcids":["https://orcid.org/0000-0001-9772-9591","https://orcid.org/0000-0003-0763-0411"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Pol","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7989,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.68891764,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"20","issue":"11","first_page":"968","last_page":"971"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.9539999961853027},{"id":"https://openalex.org/keywords/chronic-hepatitis-b","display_name":"chronic hepatitis B","score":0.8379999995231628},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.796999990940094},{"id":"https://openalex.org/keywords/interferon-alfa-2a","display_name":"interferon alfa-2a","score":0.6809999942779541},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.6759999990463257},{"id":"https://openalex.org/keywords/p24-antigenemia","display_name":"p24 antigenemia","score":0.7829999923706055},{"id":"https://openalex.org/keywords/hiv-hbv-coinfection","display_name":"HIV/HBV coinfection","score":0.6100000143051147},{"id":"https://openalex.org/keywords/people-who-use-drugs","display_name":"drug users","score":0.5339999794960022},{"id":"https://openalex.org/keywords/antiviral-treatment-response","display_name":"antiviral treatment response","score":0.546999990940094},{"id":"https://openalex.org/keywords/anti-hbe-seroconversion","display_name":"anti-HBe seroconversion","score":0.6240000128746033},{"id":"https://openalex.org/keywords/hbsag-loss","display_name":"HBsAg loss","score":0.7089999914169312},{"id":"https://openalex.org/keywords/hepatitis-c-coinfection","display_name":"hepatitis C coinfection","score":0.44200000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9293229579925537},{"id":"https://openalex.org/C2777410769","wikidata":"https://www.wikidata.org/wiki/Q2282887","display_name":"HBsAg","level":4,"score":0.7036998271942139},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5789701342582703},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5425906181335449},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5370236039161682},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.5294342041015625},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5252822637557983},{"id":"https://openalex.org/C2777382497","wikidata":"https://www.wikidata.org/wiki/Q6853","display_name":"Hepatitis B","level":2,"score":0.48997560143470764},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.47946202754974365},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.4784536361694336},{"id":"https://openalex.org/C2781228144","wikidata":"https://www.wikidata.org/wiki/Q6046441","display_name":"Interferon alfa","level":4,"score":0.46530941128730774},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.4173396825790405},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.4049529433250427},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.32041728496551514}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006509","descriptor_name":"Hepatitis B","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006509","descriptor_name":"Hepatitis B","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D006509","descriptor_name":"Hepatitis B","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006521","descriptor_name":"Hepatitis, Chronic","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006521","descriptor_name":"Hepatitis, Chronic","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D006521","descriptor_name":"Hepatitis, Chronic","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:9119186","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9119186","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gastroenterologie clinique et biologique","raw_type":"Clinical Trial"},{"id":"mag:863506","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9119186","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1978814958","https://openalex.org/W2014085175","https://openalex.org/W1976957946","https://openalex.org/W2160398630","https://openalex.org/W1978073437","https://openalex.org/W2396493750","https://openalex.org/W2084718555","https://openalex.org/W2038358235","https://openalex.org/W2429814277","https://openalex.org/W2415124599"],"abstract_inverted_index":{"OBJECTIVES:":[0],"A":[1],"pilot":[2],"study":[3],"was":[4,67,121,216,274,308],"conducted":[5],"to":[6,79,290],"evaluate":[7],"the":[8,40,83,155,171,191,199,221,227,234,255,260,283,302,346,352],"efficiency":[9],"of":[10,82,106,154,173,190,201,207,213,226,254,266,304,354],"alpha-interferon":[11,107],"treatment":[12,120,174,341],"in":[13,18,39,50,54,60,175,204,210,259,278,282,315,327,333,351],"chronic":[14,25,135],"active":[15,26,136],"hepatitis":[16,27],"B":[17],"anti-HIV-positive":[19,284],"patients.":[20,317],"METHODS:":[21],"Twenty-five":[22],"patients":[23,72,87,125,157,257,285,298],"with":[24,126,142,220,300],"(23":[28],"men":[29],"and":[30,56,92,95,98,131,134,167,180,184,206,233],"2":[31,179,205],"women,":[32],"mean":[33,63,117,240],"age:":[34],"33":[35],"years)":[36],"were":[37,44,88,139,144,185],"included":[38,145],"study.":[41],"Viral":[42],"infections":[43],"acquired":[45],"by":[46],"intravenous":[47],"drug":[48,334],"addiction":[49],"2,":[51,164],"homosexual":[52],"relations":[53],"22,":[55],"multiple":[57],"heterosexual":[58],"contacts":[59],"one.":[61,211],"The":[62,116],"CD4":[64,241],"cell":[65],"count":[66,242],"480":[68],"+/-":[69,244,250],"234/mL,":[70],"7":[71],"had":[73,230,237,263],"p24":[74,231],"antigenemia,":[75],"but":[76],"none":[77],"belonged":[78],"class":[80],"C":[81],"CDC":[84],"classification.":[85],"All":[86],"serum":[89,127,160,194,267],"HBs":[90,208],"Ag":[91,203,209],"HBV":[93,132,161,214,268,279,305],"DNA-positive,":[94,133],"delta":[96],"antigen":[97],"antibody":[99],"negative.":[100],"Patients":[101],"received":[102,287],"a":[103,238,275],"6-month":[104],"course":[105],"2a,":[108],"6":[109],"MU":[110],"subcutaneously":[111],"three":[112],"times":[113],"per":[114],"week.":[115],"follow-up":[118],"after":[119,170],"15":[122],"months.":[123],"Eighteen":[124],"anti-HIV":[128,328],"antibodies,":[129],"HBsAg":[130],"hepatitis,":[137],"who":[138,286,292],"not":[140,217,309],"treated":[141,299],"interferon,":[143],"as":[146],"controls":[147],"(mean":[148],"follow-up:":[149],"29":[150],"months).":[151],"RESULTS:":[152],"Nine":[153],"25":[156],"(36%)":[158],"lost":[159],"DNA":[162,215,269,280,306],"(1,":[163],"4,":[165,177],"6,":[166],"8":[168],"months":[169],"beginning":[172],"1,":[176,178],"1":[181],"cases,":[182],"respectively),":[183],"considered":[186],"responders.":[187],"Only":[188],"one":[189],"responders":[192,229,236,248],"developed":[193],"anti-HBe":[195],"during":[196,270],"follow-up,":[197],"despite":[198],"disappearance":[200],"HBe":[202],"Loss":[212],"clearly":[218,310],"associated":[219],"immune":[222,347],"status,":[223,348],"since":[224],"3":[225],"9":[228,235],"antigenemia":[232],"lower":[239],"(283":[243],"246/mm3)":[245],"than":[246],"non":[247],"(454":[249],"437/mm3,":[251],"NS).":[252],"Three":[253],"18":[256],"(16.7%)":[258],"control":[261],"group":[262],"spontaneous":[264],"loss":[265,281,307],"follow-up.":[271],"Thus,":[272],"there":[273],"2.15-fold":[276],"increase":[277],"alpha-interferon,":[288,301],"compared":[289],"those":[291],"did":[293],"not.":[294],"CONCLUSION:":[295],"In":[296],"HIV-positive":[297],"rate":[303],"different":[311],"from":[312],"that":[313,339],"reported":[314],"immunocompetent":[316],"As":[318],"severe":[319],"HBV-related":[320],"liver":[321],"disease":[322],"has":[323],"previously":[324],"been":[325],"described":[326],"positive":[329],"patients,":[330],"at":[331,349],"least":[332,350],"users,":[335],"these":[336],"results":[337],"suggest":[338],"this":[340],"may":[342],"be":[343],"proposed":[344],"whatever":[345],"absence":[353],"AIDS.":[355]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W863506","counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
